openPR Logo
Press release

Global Compounding Pharmacies Market to Reach a Valuation of US$ 9.7 Bn by 2021

06-01-2017 02:14 PM CET | Health & Medicine

Press release from: Persistence Market Research

Global Compounding Pharmacies Market to Reach a Valuation of US$

According to the latest market report published by Persistence Market Research titled ‘Global Market Study on Compounding Pharmacies: Asia Pacific is expected to witness highest growth by 2021’, the global compounding pharmacies market is projected to expand at a CAGR of 6% during the forecast period (2015 - 2021). Compounding pharmacies accounted for market revenue worth US$ 6.5 Bn in 2014 and the revenue is expected to increase to US$ 9.75 Bn by 2021.

Compounding pharmacies produce personalized medicines, which can be altered by dosages, medicinal strengths, forms, and medium of administration, under the guidance of licensed pharmacists and physicians. The market for compounding pharmacies – though shrouded by regulatory restrictions and product quality conformations – presents a lucrative opportunity as compounded drugs offer ease of accessibility, affordability, and administration to potential customers. The report analyzes the global compounding pharmacies market in terms of market value by end use, product, region, and therapeutic area; and provides information regarding regional market dynamics, regulations, PEST analysis, competitive landscape, current trends, market estimations, and forecast.

Among therapeutic segments, compounding pharmacies find largest application in the pain management industry followed by hormone replacement therapy and others. The hormone replacement therapy segment is expected to gain traction in the near future due to increasing demand for anti-ageing solutions. Increasing demand for high-quality dermatological products is also influencing manufacturers to opt for better quality active pharmaceutical ingredients and maintain a sterile microbial contamination-free manufacturing space. Creams and gels are the most popular products in dermatology, followed by transdermal application products, largely popular in tropical countries.

By end use type, the compounding pharmacies market is segmented into medications for adults, children, and geriatric population along with veterinary drugs. Medications for the adult segment is expected to dominate the overall compounding pharmacies market by the end of the forecast period. The segment is projected to register an above average growth rate over the forecast period. However, veterinary compounded drugs are also gaining traction as these drugs are available in alternate forms and in varying strengths not commercially available.

A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/5270

Globally, Asia Pacific is expected to dominate the market throughout the forecast period, driven by the promotion of innovative therapies and product formulations by major players in the market. Singapore and Australia are the two major growth promoting countries for compounding pharmacies in Asia Pacific. The compounding pharmacies market in Singapore is expected to increase from a current estimated value of US$ 204.9 Mn in 2015 to US$ 387.2 Mn by 2021, registering a CAGR of 11% over the forecast period. Increase in demand for drugs prone to medicinal drought, personalized dosages, and innovative therapeutic areas is expected to boost overall demand for compounding pharmacies worldwide. Upcoming regulatory harmonization and the need for manufacturing facilities to adhere to good manufacturing practices listed under the U.S. and EU pharmacopeias are set to standardize the compounding pharmacies market. Compounded drug manufacturers in Australia have been mandated to adhere by rules listed under the Australian Therapeutic Goods Administration (TGA). Latin America and Europe are the subsequent lucrative destinations for compounding pharmacies.

Key market players covered in the report include B. Braun Melsungen AG Company, Fagron, PharMEDium Services LLC, Institutional Pharmacy Solutions, Cantrell Drug Company, Triangle Compounding Pharmacies, Lorraine’s Pharmacy, and Fresenius Kabi AG.

Request to View Tables of Content @ http://www.persistencemarketresearch.com/market-research/compounding-pharmacies-market/toc

About Us 
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
 PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Compounding Pharmacies Market to Reach a Valuation of US$ 9.7 Bn by 2021 here

News-ID: 560085 • Views:

More Releases from Persistence Market Research

Location-Based Services (LBS) Market Set to Surpass US$150 Billion by 2033 Amid 5G and Smart City Revolution
Location-Based Services (LBS) Market Set to Surpass US$150 Billion by 2033 Amid …
The global Location-Based Services (LBS) Market is projected to be valued at US$ 44.2 billion in 2026 and is expected to reach US$ 150.2 billion by 2033, expanding at a remarkable CAGR of 19.1% during 2026-2033. This strong growth trajectory reflects the rapid digitization of industries, increasing smartphone penetration, and advancements in GPS and 5G connectivity. The LBS ecosystem has evolved beyond basic navigation into a sophisticated framework powering real-time
Cocoa Fiber Market to Reach US$696.8M by 2033 at 7.6% CAGR, Driven by Clean-Label Demand
Cocoa Fiber Market to Reach US$696.8M by 2033 at 7.6% CAGR, Driven by Clean-Labe …
The global cocoa fiber market is poised for significant expansion over the forecast period, driven by rising demand for functional food ingredients, clean-label formulations, and sustainable by-product utilization within the cocoa processing industry. The market is expected to grow from US$ 417.3 million in 2026 to approximately US$ 696.8 million by 2033, reflecting a healthy compound annual growth rate (CAGR) of 7.6% from 2026 to 2033. This strong growth trajectory
Non-Alcoholic Drinks Market to Hit $2,100.4B by 2033 at 8.2% CAGR on Health Trends
Non-Alcoholic Drinks Market to Hit $2,100.4B by 2033 at 8.2% CAGR on Health Tren …
The global non-alcoholic drinks market is entering a transformative growth phase, driven by evolving consumer preferences, rapid product innovation, and expanding distribution networks worldwide. The market is projected to grow from US$ 1,209.8 billion in 2026 to approximately US$ 2,100.4 billion by 2033, reflecting a robust compound annual growth rate (CAGR) of 8.2% during the forecast period from 2026 to 2033. This significant expansion underscores the increasing importance of non-alcoholic
Bamboo Packaging Market to Reach US$ 884.5 Mn by 2033 at 6.5% CAGR Driven by Plastic Substitution Demand
Bamboo Packaging Market to Reach US$ 884.5 Mn by 2033 at 6.5% CAGR Driven by Pla …
According to the latest study by Persistence Market Research, the global bamboo packaging market size is likely to be valued at US$ 569.2 million in 2026 and is expected to reach US$ 884.5 million by 2033, growing at a CAGR of 6.5% between 2026 and 2033. The growth trajectory is strongly supported by the accelerating substitution of plastic-based packaging with renewable fiber alternatives across food and beverage, cosmetics, electronics, and

All 5 Releases


More Releases for Compounding

Compounding Pharmacies Business Development Strategies for Expanding Your Market …
The global compounding pharmacies market size was US$ 8.1 billion in 2021. The global compounding pharmacies market size is estimated to reach US$ 13.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2022 to 2030. Request To Download Sample of This Strategic Report :-https://reportocean.com/industry-verticals/sample-request?report_id=bwcc17220 A compounding pharmacy is a distinctive kind of pharmacy. They can create customized medicines for the individual who
NBR Compounding Market Report Status And Outlook 2022-2027-Hexpol Compounding, P …
The NBR Compounding Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of
Global Compounding Pharmacies Market, Global Compounding Pharmacies Industry, Co …
The Compounding Pharmacies market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Compounding Pharmacies Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Compounding Pharmacies market. The report focuses on well-known providers in the global
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is
U.S. Compounding Pharmacies Market ; Eminent Players - Pencol Compounding Pharma …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is
U.S. Compounding Pharmacies Market Key Players – McKesson Corporation, Nephron …
U.S. Compounding Pharmacies Market size is set to exceed USD 7 billion by 2025; according to a new research report by Global Market Insights, Inc. Growing prevalence of chronic diseases in the U.S. such as cancer, diabetes, cardiovascular disease, respiratory diseases and obesity will drive the U.S. compounding pharmacies market growth over the forecast period. Increasing drug shortage in the country due to production delays and unavailability of previously manufactured